@article{23a10014a898414ba041847ac112d2f5,
title = "Development of the Brief Bipolar Disorder Symptom Scale for patients with bipolar disorder",
abstract = "The Brief Bipolar Disorder Symptom Scale (BDSS) is a 10-item measure of symptom severity that was derived from the 24-item Brief Psychiatric Rating Scale (BPRS24). It was developed for clinical use in settings where systematic evaluation is desired within the constraints of a brief visit. The psychometric properties of the BDSS were evaluated in 409 adult outpatients recruited from 19 clinics within the public mental health system of Texas, as part of the Texas Medication Algorithm Project (TMAP). The selection process for individual items is discussed in detail, and was based on multiple analyses, including principal components analysis with varimax rotation. Selection of the final items considered the statistical strength and factor loading of items within each of those factors as well as the need for comprehensive coverage of critical symptoms of bipolar disorder. The BDSS demonstrated good psychometric properties in this preliminary investigation. It demonstrated a strong association with the BPRS24 and performed similarly to the BPRS 24 in its relationship to other symptom measures. The BDSS demonstrated superior sensitivity to symptom change, and an excellent level of agreement for classification of patients as either responders or non-responders with the BPRS24.",
keywords = "Bipolar disorder, Brief Psychiatric Rating Scale, Rating scales, Symptom severity",
author = "Dennehy, {Ellen B.} and Trisha Suppes and Crismon, {M. Lynn} and Marcia Toprac and Carmody, {Thomas J.} and Rush, {A. John}",
note = "Funding Information: This research was supported by National Institute of Mental Health (NIMH) Grant MH-53799, the Robert Wood Johnson Foundation, the Meadows Foundation, the Lightner-Sams Foundation, the Nanny Hogan Boyd Charitable Trust, the Texas Department of Mental Health and Mental Retardation, the Center for Mental Health Services, the Department of Veterans Affairs, Health Services Research and Development Research Career Scientist Award (RCS92-403), the Betty Jo Hay Distinguished Chair in Mental Health and the Rosewood Corporation Chair in Biomedical Science (AJR), the United States Pharmacopoeia Convention, Inc., Mental Health Connections, a partnership between Dallas County Mental Health and Mental Retardation (MHMR) and the Department of Psychiatry of the University of Texas Southwestern Medical Center, which receives funding from the Texas State Legislature and the Dallas County Hospital District and the University of Texas at Austin College of Pharmacy, and the Southwestern Drug Corporation Centennial Fellowship in Pharmacy (MLC). The following pharmaceutical companies provided unrestricted educational grants: Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, Forest Laboratories, GlaxoSmithKline, Janssen Pharmaceutica, Novartis, Organon, Pfizer, Inc. and WyethAyerst Laboratories, Inc. We express our gratitude to the personnel at each Community Mental Health Center for allowing us to conduct TMAP Phase 3 with their staff and patients, including Andrews Center, Tyler; Center for Health Care Services, San Antonio; Life Management Center, El Paso; Lubbock Regional MHMR Center; MHMRA of Harris County, Houston; Tri-County MHMR Services, Conroe; and Tropical Texas MHMR Services, Edinburgh, Harlingen and Brownsville. ",
year = "2004",
month = jun,
day = "30",
doi = "10.1016/j.psychres.2004.02.009",
language = "English (US)",
volume = "127",
pages = "137--145",
journal = "Psychiatry research",
issn = "0165-1781",
publisher = "Elsevier Ireland Ltd",
number = "1-2",
}